Omicron News and Research

RSS
Booster doses provide strong protection against hospitalization and death from COVID-19

Booster doses provide strong protection against hospitalization and death from COVID-19

30 Mar 2022
Inconsistency in disease severity across SARS-CoV-2 variants

Inconsistency in disease severity across SARS-CoV-2 variants

30 Mar 2022
Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

30 Mar 2022
ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

30 Mar 2022
Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

30 Mar 2022
Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

30 Mar 2022
Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

30 Mar 2022
Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

29 Mar 2022
Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

29 Mar 2022
A bioinformatics approach for detecting SARS-CoV-2 co-infections

A bioinformatics approach for detecting SARS-CoV-2 co-infections

29 Mar 2022
FDA approves second COVID-19 booster dose for older and immunocompromised individuals

FDA approves second COVID-19 booster dose for older and immunocompromised individuals

29 Mar 2022
Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

29 Mar 2022
Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

29 Mar 2022
Study tracks the rapid shift from Omicron BA.1 to BA.2 sub-variant dominance in Sweden

Study tracks the rapid shift from Omicron BA.1 to BA.2 sub-variant dominance in Sweden

29 Mar 2022
Immune response dynamics following COVID-19 heterologous and homologous vaccinations

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

29 Mar 2022
Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

29 Mar 2022
New compound delivered in a nasal spray effectively treats delta variant infection in mice

New compound delivered in a nasal spray effectively treats delta variant infection in mice

29 Mar 2022
Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

28 Mar 2022
Natural SARS-CoV-2 antibodies persist for six months in children

Natural SARS-CoV-2 antibodies persist for six months in children

28 Mar 2022
Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

28 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback